Post‐hoc analysis investigating the safety and efficacy of brexpiprazole in Japanese patients with schizophrenia who were switched from other antipsychotics in a long‐term study (Secondary Publication)
Abstract A post hoc analysis was performed using data obtained over eight weeks from 200 Japanese patients with schizophrenia who were switched to brexpiprazole monotherapy in a long‐term treatment study. The 8‐week period comprised of a 4‐week switching phase and a 4‐week post‐switch phase. For the...
Main Authors: | Jun Ishigooka, Tomohiro Usami, Shuichi Iwashita, Yoshitsugu Kojima, Satoshi Matsuo |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-06-01
|
Series: | Neuropsychopharmacology Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/npr2.12107 |
Similar Items
-
Brexpiprazole in patients with schizophrenia with or without substance use disorder: an observational study
by: Ginevra Lombardozzi, et al.
Published: (2023-12-01) -
Long-Term Efficacy and Safety of Brexpiprazole in Elderly Japanese Patients with Schizophrenia: A Subgroup Analysis of an Open-Label Study
by: Inada K, et al.
Published: (2020-10-01) -
Analysis of the effect of brexpiprazole on sleep architecture in patients with schizophrenia: A preliminary study
by: Yusuke Arai, et al.
Published: (2023-03-01) -
Subjective assessment of brexpiprazole in patients with schizophrenia: a prospective observational study
by: Rina Yokoi, et al.
Published: (2023-08-01) -
Brexpiprazole for the Treatment of Schizophrenia in Adults: An Overview of Its Clinical Efficacy and Safety and a Psychiatrist’s Perspective
by: Watanabe Y, et al.
Published: (2020-12-01)